- Basic information
- CohesinDB ID: CDBP00413395
- Locus: chr21-15014507-15017598
-
Data sourse: ENCSR000EFJ, ENCSR956LGB, GSE206145-GSE177045, ENCSR501LQA, ENCSR000HPG, ENCSR676MJK, GSE206145, GSE85526, ENCSR981FDC, GSE206145-NatGen2015, ENCSR198ZYJ, GSE68388, GSE165895
-
Cell type: MCF-7, RPE, Fibroblast, HEKn, Neurons-H1, A-549, IMR-90, HuCC-T1, HFFc6
- DNA Sequence of binding site:
UCSC hg38
- Cohesin category
- Peak occupancy ratio: 6% samples have this site.
- Cell specificity (0: conserved, 1: cell type specific): 0.900
- Subunit: NIPBL,SA1,Rad21,SMC1,SA2,Mau2,SMC3
-
CTCF binding site: CTCF
CTCF motif: False
- Genomic location: TSS
- 3D genome
- TAD boundary: Boundary
- Chromatin hubs: Hub
-
Hi-C loops: True
Hi-ChIP loops: False
ChIA-PET loops: True
- Compartment:
52% Hi-C samples shows Compartment A
- Cis-regulatory elements
- Enhancer (Fantom5): Enhancer
- Super enhancer (SEdb): True
-
Chromatin annotation:
"5_TxWk": 50%,
"15_Quies": 26%,
Note: The percentage represent how many of the 127 Roadmap datasets show the indicated state (top 2).
-
Co-bound Transcriptional factors: FOSL1, PGR, SOX2, FOXA1, MEN1, ATF3, CHD7, PRDM1, TP63, TEAD1, KLF6, SNAI2, ESR1, HNF1B, CTCF, JUN, TCF12, EP300, TEAD4, GATAD2A, PDX1, POU2F2, TOP2A, DUX4, SRF, ERG, HOXC5, ETS1, MYC, SMARCA4, RAD21, LHX2, GRHL3, NKX2-1, GABPA, STAT3, RCOR1, VDR, NR3C1, CEBPB, ZNF750, KMT2A, MRTFA, ZHX2, SPI1, IRF1, GATA2, SIX2, FLI1, ZNF766, MRTFB, BCL6, MAFG, CEBPA, SMC1A, EZH2phosphoT487, SIN3A, SMAD3, ZNF770, ZNF792, RUNX2, GATA4, ARNT, PBX4, FOS, CDK8, MED1, CEBPD, SUPT16H, C11orf30, RBM22, MAFK, HNF4A, MLLT1, PAX7, FOXA2, PAF1, GTF2B, MAFF, KDM1A, RELA, NEUROD1, JUNB, HIF1A, OTX2, GATA3, MAX, AGO2, HAND2, CEBPG, KLF4, TP53, NFKB1, MYOD1, PHOX2B, BRD2, BHLHE40, AR, BRD4, ZNF316, FOSL2
- Target gene symbol (double-evidenced CRMs): NRIP1
- Function elements
- Human SNPs: Heart_rate_response_to_beta_blockers_(atenolol_monotherapy)
- Number of somatic mutations (coding): 63
- Number of somatic mutations (non-coding): 21
- Related genes and loops